摘要
Abstract
Objective To explore the clinical effect of Cefotaxime Sodium Sulbactam Sodium combined with Ambrocol Oral Solution in the treatment of children with pneumonia.Methods A total of 80 children with pneumonia admitted to Sanshandao Community Health Service Center in Laizhou City,Shandong Province from February 2020 to April 2022 were selected as the study objects.All the children were divided into the reference group(40 cases)and the study group(40 cases)according to the coin toss method.The reference group was treated with Ambrocol Oral Solution,and the study group was treated with Cefotaxime Sodium Sulbactam Sodium combined with Ambrocol Oral Solution.The clinical efficacy,time of clinical symptom disappearance and hospitalization,incidence of adverse reactions,and inflammation factors were compared between the two groups.Results The total effective rate of treatment in the study group was higher than that in the reference group,and the difference was statistically significant(P<0.05).The disappearance time of asthma,lung rales,fever,and cough and hospitalization time in the study group were shorter than those in the reference group,and the differences were statistically significant(P<0.05).The total incidence of adverse reactions in the study group was lower than that in the reference group,and the difference was statistically significant(P<0.05).After treatment,the levels of interleukin-8,tumor necrosis factor-α,and interleukin-6 in the study group were lower than those in the reference group,and the differences were statistically significant(P<0.05).Conclusion The use of Cefotaxime Sodium Sulbactam Sodium combined with Ambrocol Oral Solution in the treatment of children with pneumonia can improve clinical efficacy,effectively shorten the disappearance time of clinical symptoms and hospitalization time,reduce adverse reactions and the levels of inflammation factors,which is worthy of promotion.关键词
头孢噻肟钠舒巴坦钠/氨溴特罗口服溶液/小儿肺炎/不良反应Key words
Cefotaxime Sodium Sulbactam Sodium/Ambrocol Oral Solution/Children with pneumonia/Adverse reaction分类
医药卫生
